Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-06-29

FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (Natco Pharma USA LLC)

View source ↗

Summary

FDA approved a supplemental application for Bisoprolol Fumarate (Natco Pharma USA LLC), resulting in labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisoprolol Fumarate (bisoprolol fumarate)

Snippet

SUPPL AP for BISOPROLOL FUMARATE (BISOPROLOL FUMARATE)